TrialThe oncologist2026

Atezolizumab and motixafortide, cobimetinib or simlukafusp alfa in pretreated advanced pancreatic cancer: phase I/IIb MORPHEUS-PDAC umbrella study.

Gulam A Manji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.